At Nomisma Healthcare Pvt. Ltd., we are pushing the boundaries of dental technology with our advanced PLGA (Poly(lactic-co-glycolic acid)) polymers, specifically designed for encapsulation of lidocaine in dental cosmetic procedures.

🔬 Why Choose PLGA for Lidocaine Encapsulation?

In the fight against cancer, innovation is key. One exciting advancement is the use of PEG-PLGA nanoparticles in triple chemotherapy.

This innovative approach is helping to make cancer treatments more precise, powerful, and patient-friendly.

#Nanotechnology #CancerTreatment #Chemotherapy #PharmaInnovation #Oncology

What is Triple Chemotherapy?

Triple chemotherapy is a cancer treatment strategy that uses three different chemotherapy drugs together to enhance effectiveness.

This approach targets cancer cells through multiple mechanisms, increasing the likelihood of killing them while reducing the risk of drug resistance. It often allows for lower doses of each drug, helping to minimize side effects. Triple chemotherapy is commonly used for aggressive cancers, such as breast and lung cancer, and is designed to provide a more comprehensive attack on tumors compared to single or double-agent therapies.

Optimal PEG-PLGA Ratios: 1:1 to 1:5 ratio

Lactic Acid (LA) to Glycolic Acid (GA) Ratio: 75:25 to 85:15 ratio.

For more information about our product and services contact us at: [email protected]

email: [email protected]